Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (symbol: PHR) is a leading provider of comprehensive software solutions designed to enhance the operational and financial performance of healthcare organizations. Through its innovative SaaS-based technology platform, Phreesia enables medical groups of all sizes to streamline their administrative, financial, and clinical operations, thereby allowing healthcare staff to focus more on delivering exceptional patient care.
The Phreesia Platform offers a robust suite of integrated solutions that manage various aspects of patient interactions. These solutions include patient access, registration, payments, and clinical support, all aimed at optimizing patient health outcomes. By activating patients in their care, Phreesia ensures that healthcare providers can offer more personalized and efficient services.
Phreesia's flexible and scalable platform is trusted by leading healthcare organizations to revolutionize their point of service. The platform encompasses a wide range of technologies and services, from initial patient contact and registration to appointment scheduling, payment processing, and post-appointment patient surveys. This comprehensive range of services drives tangible results, enhancing both patient and provider experiences.
Recent achievements and current projects at Phreesia include continuous updates to their software to ensure compatibility with the latest technological advancements and regulatory requirements. The company also focuses on forming strategic partnerships that further enhance the capabilities of their platform.
In terms of financial condition, Phreesia has shown consistent growth, driven by the increasing demand for efficient healthcare management solutions. The company's ability to adapt to the evolving needs of the healthcare industry makes it a significant player in the market.
Phreesia has announced that General Counsel Allison Hoffman has been recognized in The Software Report’s list of the Top 50 Women Leaders in SaaS of 2021. This marks the fourth consecutive year that a Phreesia leader has achieved this honor. Hoffman, with over 25 years of legal expertise, joined Phreesia in 2020, overseeing the Legal, Compliance, Risk, Privacy, and Security teams. Her role also includes sponsoring the Phreesia Women’s Network. The Software Report emphasized the impact of women in executive positions in driving organizational success during the COVID-19 era.
Seminal Capital Holdings announces key appointments to its Seminal Healthcare team, including Victor Kats, Mark Miller, and Lindsey Watson. These professionals bring extensive experience in healthcare technology and investment. Kats, with over 25 years in the industry, previously led the Healthcare Technology Practice at Ascension Ventures. Miller and Watson also come with a wealth of expertise from notable firms. Seminal Healthcare aims to enhance its impact investing focus and provide strategic support to healthcare companies.
MercyOne and Phreesia have launched an initiative to enhance patient care by streamlining the assessment of social needs affecting health. By utilizing Phreesia's electronic screening solutions, MercyOne has conducted over 35,000 screenings, identifying that 18% of patients had unmet social needs. This innovative approach aims to improve patient communication, privacy, and connection to essential resources. The partnership reflects a commitment to health equity and personalized care, enhancing the overall well-being of communities served.
Phreesia, traded under the ticker PHR, has successfully renewed its HITRUST CSF Certification, reinforcing its commitment to information security. This status confirms that its patient intake platform meets essential regulations and effectively manages risk.
Wes Shriner, Phreesia’s Senior Director of Information Security, emphasized the company’s focus on safeguarding sensitive health and financial data. The HITRUST certification positions Phreesia among a select group of organizations globally recognized for high standards in information risk management.
Phreesia, Inc. (NYSE: PHR) reported a revenue of $51 million for Q2 FY 2022, marking a significant 46% increase from the same quarter last year. The average number of provider clients rose by 19% to 1,987, and average revenue per client increased by 14% to $19,720. However, the company recorded a negative adjusted EBITDA of $11 million, a decline from a positive $1.2 million in Q2 FY 2021. Phreesia has raised its fiscal 2022 revenue outlook to $195-$198 million, up from $191-$194 million, but anticipates increased cash outflow due to ongoing hiring and infrastructure investments.
Phreesia, Inc. (NYSE: PHR) is set to hold a conference call on September 2, 2021, at 8:30 a.m. ET to discuss its fiscal Q2 2022 financial results. A press release detailing these results will be available after the market close on September 1, 2021. The conference call can be accessed by calling (866) 211-4557 or (647) 689-6750 internationally, using conference code 7489917. Phreesia’s platform aids healthcare organizations in streamlining the patient intake process, improving both patient engagement and clinical efficiency.
Phreesia has partnered with the developers of the SEEK model to provide pediatric primary care providers with a screening tool for adverse childhood experiences (ACEs) and negative social determinants of health (SDOH). This automated questionnaire enhances pediatricians' ability to deliver comprehensive care and address family issues such as parental depression and substance use. Studies show that implementing SEEK leads to significantly lower child maltreatment incidents. The SEEK tool will improve pediatric practices by allowing private completion via mobile devices before visits, enabling informed discussions during appointments.
Phreesia has launched Appointment Accelerator, an innovative AI-driven solution designed to automatically fill cancelled appointments and enhance patient access without staff involvement. This tool reduces the average time to fill an open slot to just 5.3 minutes, significantly improving efficiency and reducing wait times by 18.5 days. Medical practices using this solution can fill an average of 15.6 appointments per provider monthly, thereby increasing patient volume and minimizing revenue loss from no-shows. This aligns with Phreesia's goal of improving the healthcare experience.
Phreesia reported a 45% year-over-year revenue increase to $48.3 million for Q1 FY2022, driven by a rise in provider clients, up 17% to 1,902. Average revenue per client also rose by 21% to $20,222. However, adjusted EBITDA fell to $0.1 million from $1.5 million last year. Cash and equivalents grew significantly to $450.7 million following a $245.8 million stock offering. The company raised its revenue guidance for FY2022 to $191-$194 million, up from $178-$186 million, despite anticipating increased cash outflow due to hiring and infrastructure investments.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
What does Phreesia, Inc. do?
What is the Phreesia Platform?
How does Phreesia benefit healthcare organizations?
What are some of Phreesia's recent achievements?
What makes Phreesia's platform scalable and flexible?
Who uses Phreesia's services?
What is Phreesia's approach to patient activation?
How does Phreesia enhance patient-provider interactions?
What are some key features of the Phreesia Platform?
How is Phreesia performing financially?
